Picture of Albert David logo

524075 Albert David Share Price

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Momentum

Relative Strength (%)
1m-1.35%
3m-34.25%
6m-34.51%
1yr-31.91%
Volume Change (%)
10d/3m-47.11%
Price vs... (%)
52w High-51.65%
50d MA-2.82%
200d MA-31.01%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital2.38%
Return on Equity10.59%
Operating Margin2.88%

Financial Summary

Year End 31st MarUnit202020212022202320242025E2026ECAGR / Avg
Total RevenueIN₹m3,207.952,474.53,135.113,415.643,624.62n/an/a2.72%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+7.36+15.73+51.74+7.92+109.78n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202531st Mar 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Albert David EPS forecast chart

Profile Summary

Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.

Directors

Last Annual
March 31st, 2024
Last Interim
December 31st, 2024
Incorporated
November 16th, 1938
Public Since
June 14th, 2016
No. of Shareholders
11,266
No. of Employees
1,497
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
in flag iconBombay Stock Exchange
Shares in Issue
5,707,162

524075 Share Price Performance

Upcoming Events for 524075

Q4 2025 Albert David Ltd Earnings Release

Q1 2025 Albert David Ltd Earnings Release

Albert David Ltd Annual Shareholders Meeting

Similar to 524075

Picture of Aayush Wellness logo

Aayush Wellness

in flag iconBombay Stock Exchange

Picture of Achyut Healthcare logo

Achyut Healthcare

in flag iconBombay Stock Exchange

Picture of Adline Chem Lab logo

Adline Chem Lab

in flag iconBombay Stock Exchange

Picture of MPS Pharmaa logo

MPS Pharmaa

in flag iconBombay Stock Exchange

Picture of Ambalal Sarabhai Enterprises logo

Ambalal Sarabhai Enterprises

in flag iconBombay Stock Exchange

FAQ